This learning plan, based on IRIS Registry measure IRIS44: Visual Field Progression in Glaucoma, reviews tools to assess the risk of glaucoma progression and the factors to consider when deciding stepwise treatment.

This study assessed the clinical efficacy and safety of primary selective laser trabeculoplasty (SLT) for open-angle glaucoma (OAG) and ocular hypertension.

This presentation from AGS 2019 is a debate among an expert panel on how to treat various cases on glaucoma, the premise being that the physician should limit outside influences that might stop them from providing the same type of care for their patients that they would for a family member.

In this webinar, Drs. Patel, Camejo, Blieden, Shen, and Reznik provide the comprehensive ophthalmologist with an overview of some of the major advances in the diagnosis and management of glaucoma.

This study evaluates the efficacy of netarsudil 0.02% ophthalmic solution in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

This video discusses perimetry, OCT, visual field testing, computerized algorithms, Netarsudil (Rhopressa), latanoprostene bunod (Vyzulta), MP-CPC, CW-CPC, trabeculectomy, aqueous shunts, and MIGS.

This video describes the surgical management of a complicated Axenfeld-Rieger syndrome (ARS) case.

A 76-year-old woman with a known history of dry eye presents with complaints of increased foreign-body sensation and irritation of both eyes.

Dr. Marlene Moster discusses the use of punctal plugs for treating glaucoma. Although there are no FDA-approved drug delivery systems for glaucoma, 2 companies are performing clinical trials to assess the feasibility of this delivery route.